Search
Search
Single-cell sequencing is cell-by-cell RNA transcription that can provide more similar insights into brain tumor biology. It can reveal mutations and structural variants that occur in the genomes of brain tumor cells, which often have extremely high mutation rates. Single-cell sequencing technology helps researchers dissect the heterogeneity of cells. With this information, researchers can characterize the clonal structure of brain tumor cells and track the progression and extent of disease spread.
Many brain diseases in the field of brain research lack single-cell studies, and the interactions between various types of cells in developing the disease need to be urgently explored. Alfa Cytology offers single-cell sequencing technology that can provide insight into the pathogenesis of brain tumors in terms of cell types and multi-omics, and offer new ideas for tumor prevention and treatment.
Methods | Description |
Mechanical method | We mechanically cut and disrupt tissue by cutting, blocking, pipette blowing, etc. |
Enzymatic method | We use a variety of enzymes such as collagenase, trypsin, neutral protease, elastase, etc., to digest the tissue and cleave the protein bonds. |
Combined solution | With the help of automated systems, mechanical and enzymatic methods can be performed sequentially or simultaneously to achieve a wider range of cleavage. |
Methods | Description |
Centrifugation | We can enrich cells according to their size, shape, or density by density gradient centrifugation. |
Bead-based enrichment | We enrich your cell population of interest (including live cells) by positive/negative screening with magnetic beads conjugated to antibodies. |
Flow cytometric fluorescence sorting | We enrich your cell population of interest (including live cells) by positive/negative screening with fluorochrome-conjugated antibodies. |
Microfluidic cell sorting | We use low-pressure microfluidics based on positive/negative screening with fluorochrome-conjugated antibodies to enrich your cell population of interest. |
Methods: cell counter, flow cytometry.
Evaluation metrics: cell size, viability, presence of aggregates, appropriate concentration.
Alfa Cytology offers single-cell sequencing technology that allows you to take a new perspective on brain tumor and neuroscience problems and can help you discover genomic variants in brain tumor cells. It will help you to deepen your understanding of the cellular state, the nature of transcription and regulation of gene expression, and even the pathological process of brain tumors. Please contact our staff to learn how we can do this.